Seer, Inc. (SEER)

Market Cap	114.92M
Revenue (ttm)	16.38M
Net Income (ttm)	-79.35M
Shares Out	55.79M
EPS (ttm)	-1.36
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,780
Open	2.140
Previous Close	2.160
Day's Range	2.045 - 2.140
52-Week Range	1.620 - 2.625
Beta	1.60
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2025

About SEER

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratori...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 134
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2024, Seer, Inc.'s revenue was $14.17 million, a decrease of -14.95% compared to the previous year's $16.66 million. Losses were -$86.60 million, 0.37% more than in 2023.